These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36452226)

  • 1. Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating
    Jacobsson S; Golparian D; Oxelbark J; Wicha WW; da Costa RMA; Franceschi F; Brown D; Louie A; Gelone SP; Drusano G; Unemo M
    Front Pharmacol; 2022; 13():1035841. PubMed ID: 36452226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against
    Jacobsson S; Golparian D; Oxelbark J; Alirol E; Franceschi F; Gustafsson TN; Brown D; Louie A; Drusano G; Unemo M
    Front Pharmacol; 2021; 12():682135. PubMed ID: 34093206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against
    Jacobsson S; Golparian D; Oxelbark J; Kong FYS; Da Costa RMA; Franceschi F; Brown D; Louie A; Drusano G; Unemo M
    Front Pharmacol; 2023; 14():1291885. PubMed ID: 38130409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
    Unemo M; Golparian D; Oxelbark J; Kong FYS; Brown D; Louie A; Drusano G; Jacobsson S
    J Antimicrob Chemother; 2024 May; 79(5):1006-1013. PubMed ID: 38497988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic Evaluation of Zoliflodacin Treatment of
    Jacobsson S; Golparian D; Oxelbark J; Franceschi F; Brown D; Louie A; Drusano G; Unemo M
    Front Pharmacol; 2022; 13():874176. PubMed ID: 35496288
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jacobsson S; Paukner S; Golparian D; Jensen JS; Unemo M
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin.
    Eraikhuemen N; Julien D; Kelly A; Lindsay T; Lazaridis D
    Infect Dis Ther; 2021 Mar; 10(1):149-163. PubMed ID: 33528794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic.
    Veve MP; Wagner JL
    Pharmacotherapy; 2018 Sep; 38(9):935-946. PubMed ID: 30019769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
    Zhanel GG; Deng C; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Berry L; Schweizer F; Zhanel MA; Irfan N; Bay D; Lagacé-Wiens P; Walkty A; Mandell L; Lynch JP; Karlowsky JA
    Drugs; 2021 Feb; 81(2):233-256. PubMed ID: 33247830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Distribution of [
    Wicha WW; Henson C; Webbley K; Gelone SP
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0035522. PubMed ID: 35862748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Data Are Predictive of
    Connolly KL; Eakin AE; Gomez C; Osborn BL; Unemo M; Jerse AE
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber
    VanScoy BD; Scangarella-Oman NE; Fikes S; Min S; Huang J; Ingraham K; Bhavnani SM; Conde H; Ambrose PG
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32661002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level in vitro resistance to gentamicin acquired in a stepwise manner in Neisseria gonorrhoeae.
    Golparian D; Jacobsson S; Holley CL; Shafer WM; Unemo M
    J Antimicrob Chemother; 2023 Jul; 78(7):1769-1778. PubMed ID: 37253051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.
    Unemo M; Golparian D; Eyre DW
    Methods Mol Biol; 2019; 1997():37-58. PubMed ID: 31119616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.
    Yasuda M; Hatazaki K; Ito S; Kitanohara M; Yoh M; Kojima M; Narita H; Kido A; Miyata K; Deguch T
    Sex Transm Dis; 2017 Mar; 44(3):149-153. PubMed ID: 28178112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines.
    Barbee LA; St Cyr SB
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S95-S111. PubMed ID: 35416971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.